Skip to main content
Current Pharmaceutical Design publishes timely in-depth reviews covering all aspects of current research in rational drug design. Each issue is devoted to a single major therapeutic area. A Guest Editor who is an acknowledged authority in a therapeutic field has solicits for each issue comprehensive and timely reviews from leading researchers in the pharmaceutical industry and academia.

Each thematic issue of Current Pharmaceutical Design covers all subject areas of major importance to modern drug design, including: medicinal chemistry, pharmacology, drug targets and disease mechanism.

Publisher: Bentham Science Publishers

More about this publication?
Volume 12, Number 4, 2006

Articles

Favourites:
ADD
Favourites:
ADD

Brain Neuronal Nicotinic Receptors as New Targets for Drug Discovery
pp. 407-428(22)
Authors: Gotti, C.; Riganti, L.; Vailati, S.; Clementi, F.

Favourites:
ADD

Na+ Channel Pharmacology and Molecular Mechanisms of Gating
pp. 429-442(14)
Authors: Yamaoka, K.; Vogel, S. M.; Seyama, I.

Favourites:
ADD

L-Type Calcium Channels
pp. 443-457(15)
Author: Triggle, David J.

Favourites:
ADD

Modulation of Potassium Channels as a Therapeutic Approach
pp. 459-470(12)
Authors: Lawson, K.; McKay, N. G.

Favourites:
ADD
Favourites:
ADD

Membrane Ion Channels and Diabetes
pp. 485-501(17)
Authors: Proks, P.; Lippiat, J. D.

Favourites:
ADD

Recent Progress in Pharmacological and Non-Pharmacological Treatment Options of Major Depression
pp. 503-515(13)
Authors: Baghai, Thomas C.; Moller, Hans-Jurgen; Rupprecht, Rainer

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content